Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DarioHealth Corp.
Report date April 23, 2018 · Filed April 25, 2018
Section 16 reporting ended · disclosed 2018-04-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,957 |
Reported balance
After 2018-04-23 transaction · row 1
1 source rowRow 1 · 2018-04-23 · Grant · Acquired 3,335 · Balance 13,957 F1: The reporting person was awarded such securities in exchange for waiving director fees owed for part of the first quarter of 2018, until his retirement from the board, in the amount of $5,138.89. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 1,388,889 |
Reported balance
Holding disclosure · report date 2018-04-23 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,388,889 F2: The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd Digital Health L.P., which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd Digital Health L.P. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person was awarded such securities in exchange for waiving director fees owed for part of the first quarter of 2018, until his retirement from the board, in the amount of $5,138.89.
F2: The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd Digital Health L.P., which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd Digital Health L.P. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 23, 2018 Filed Apr 25, 2018 20:06 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 3,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-022371 · tv491860_4.xml · nonDerivative · entry 1 Bahagon Yossi · CIK 0001697541 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,957 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for part of the first quarter of 2018, until his retirement from the board, in the amount of $5,138.89. Read SEC document |
| January 04, 2018 Filed Jan 8, 2018 21:08 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 3,983 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-18-001294 · tv482691_4.xml · nonDerivative · entry 1 Bahagon Yossi · CIK 0001697541 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,622 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the fourth quarter of 2017 in the amount of $6,250. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | OtherWarrant to purchase Common Stock · Derivative | 892,858 | $0.00 Strike: $3.50 | $0.00 |
DisclosureSEC source: 0001144204-17-059419 · tv479694_form4.xml · derivative · entry 3 Bahagon Yossi · CIK 0001697541 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 892,858 shares Expires 2022-01-09 F1 · ownership.nature: On November 13, 2017, DarioHealth Corp. (the "Company") and OurCrowd Digital Health L.P. ("OurCrowd") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein. Read SEC document |
| November 13, 2017 Filed Nov 15, 2017 21:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 496,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-059419 · tv479694_form4.xml · nonDerivative · entry 1 Bahagon Yossi · CIK 0001697541 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,388,889 F1 · shares: On November 13, 2017, DarioHealth Corp. (the "Company") and OurCrowd Digital Health L.P. ("OurCrowd") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein. F1 · balance_after: On November 13, 2017, DarioHealth Corp. (the "Company") and OurCrowd Digital Health L.P. ("OurCrowd") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein. F1 · ownership.nature: On November 13, 2017, DarioHealth Corp. (the "Company") and OurCrowd Digital Health L.P. ("OurCrowd") entered into a warrant exchange agreement whereby OurCrowd agreed to surrender a warrant to purchase 892,858 shares of the Company's common stock in exchange for 496,031 restricted shares of the Company's common stock. The amounts shown represent the beneficial ownership or the issuer's securities by OurCrowd, which may be deemed attributable to Mr. Bahagon because Mr. Bahagon is a Managing Partner of OurCrowd. Mr. Bahagon disclaims beneficial ownership of the securities set forth herein except to the extent of their pecuniary interest therein. Read SEC document |
| October 23, 2017 Filed Oct 25, 2017 20:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 3,367 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-054092 · tv477604_4.xml · nonDerivative · entry 1 Bahagon Yossi · CIK 0001697541 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,639 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the third quarter of 2017 in the amount of $6,250. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 2,703 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-036435 · v470575_4.xml · nonDerivative · entry 1 Bahagon Yossi · CIK 0001697541 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,272 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the second quarter of 2017 in the amount of $6,250. Read SEC document |
| April 13, 2017 Filed Apr 17, 2017 20:16 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 569 | $0.00 | $0.00 |
DisclosureSEC source: 0001144204-17-020711 · v464363_4.xml · nonDerivative · entry 1 Bahagon Yossi · CIK 0001697541 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 569 F1 · shares: The reporting person was awarded such securities in exchange for waiving director fees owed for the first quarter of 2017 in the amount of $2,083.33. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.